[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-338533-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-338533-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","lymphocyte-infiltration-in-breast-cancer-a-promising-prognostic-indicator","Lymphocyte infiltration in breast cancer - A promising prognostic indicator","","Breast cancer remains a major cause of cancer-related mortality among women worldwide, creating urgent need for dependable prognostic markers that can steer treatment and improve outcomes. Tumor-infiltrating lymphocytes (TILs) have emerged as key indicators, since higher TIL levels often align with better survival and stronger therapy responses. This review explains lymphocyte infiltration mechanisms, their clinical relevance across subtypes, and their use as predictive biomarkers in breast cancer management, including implications for immunotherapy.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/lymphocyte-infiltration-in-breast-cancer-a-promising-prognostic-indicator/338533/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/lymphocyte-infiltration-in-breast-cancer-a-promising-prognostic-indicator/338533.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What makes tumor-infiltrating lymphocytes (TILs) important in breast cancer prognosis?","Question",{"text":63,"@type":64},"Higher levels of TILs are associated with improved overall survival and disease-free survival, indicating stronger prognostic value across breast cancer contexts.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Which biological mechanisms support lymphocyte infiltration into tumors?",{"text":68,"@type":64},"Lymphocyte recruitment and activity are facilitated by chemokine signaling, antigen presentation, and immune checkpoint interactions, such as the PD-1/PD-L1 axis.",{"name":70,"@type":61,"acceptedAnswer":71},"Do TILs provide different prognostic value across breast cancer subtypes?",{"text":72,"@type":64},"Yes. The review highlights the most significant prognostic value in triple-negative and HER2-positive breast cancers, where TIL density correlates with improved outcomes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},338533,1790291326,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":107,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","®  \n Narrative Review   \nLymphocyte infiltration in breast cancer A promising prognostic indicator  \nEmmanuel Ifeanyi Obeagu, PhDa ,* , Getrude Uzoma Obeagu, BNScb  \n\n| Abstract\u003Cbr>Breast cancer is a leading cause of cancer-related mortality among women worldwide, necessitating the identification of reliable prognostic markers to guide treatment and improve patient outcomes. Recent research has highlighted the prognostic significance of tumor-infiltrating lymphocytes (TILs) in breast cancer, with high levels of TILs being associated with improved survival rates and better responses to therapy. This review delves into the mechanisms driving lymphocyte infiltration, its clinical implications, and the potential for TILs to serve as predictive biomarkers in breast cancer management. The presence of TILs within the tumor microenvironment reflects a dynamic interplay between tumor cells and the host immune system. Chemokine signaling, antigen presentation, and immune checkpoint interactions are key mechanisms that facilitate the recruitment and activity of lymphocytes at the tumor site. Clinically, the density of TILs varies across breast cancer subtypes, with the most significant prognostic value observed in triple-negative and HER2-positive breast cancers. High TIL levels correlate with improved overall survival and diseasefree survival, underscoring their potential as a valuable prognostic indicator. Therapeutically, the role of TILs has opened new avenues in breast cancer treatment, particularly in the realm of immunotherapy. Immune checkpoint inhibitors, adoptive cell therapy, and combination therapies leveraging TILs are being explored to enhance antitumor responses. As research progresses, the integration of TIL assessment into routine clinical practice could revolutionize personalized treatment strategies, ultimately improving prognostic accuracy and patient outcomes in breast cancer care. |\n| --- |\n| Abbreviations: CAR = chimeric antigen receptor, CTLs = cytotoxic T lymphocytes, DFS = disease-free survival, IHC = immunohistochemical, NK = natural killer, OS = overall survival, PD-1 = programmed death-1, Th cells = helper T cells, TILs = tumor-infiltrating lymphocytes, TLS = tertiary lymphoid structures, TME = tumor microenvironment, Tregs = regulatory T cells. |\n| Keywords: breast cancer, immunotherapy, prognosis, tumor microenvironment, tumor-infiltrating lymphocytes (TILs) |\n\n1. Introduction  \nBreast cancer is one of the most prevalent cancers among women globally and remains a significant cause of cancerrelated mortality.[1] Despite advances in early detection and treatment, the heterogeneity of breast cancer poses challenges in predicting clinical outcomes and tailoring effective therapies. Traditionally, prognostic indicators such as tumor size, grade, lymph node involvement, and hormone receptor status have been utilized to guide clinical decisions. [2] However, these factors alone often fall short in providing a comprehensive prognosis, highlighting the need for additional reliable biomarkers. Recent research has brought attention to the immune system’s role in cancer progression and response to treatment, particularly the presence of tumor-infiltrating lymphocytes (TILs) within the tumor microenvironment (TME) . [3] TILs area heterogeneous population of immune cells, predominantly comprising T cells, but also including B cells and natural killer (NK) cells. Their infiltration into tumors indicates an active immune response against the malignancy, which can have significant prognostic implications. [4] The concept of immune  \nsurveillance, where the immune system recognizes and eliminates emerging tumor cells, is foundational for understanding the role of TILs. [5] Tumors, however, can develop mechanisms to evade immune detection and destruction. The presence of TILs within a tumor signifies an ongoing battle between the immune system and cancer cells. This dynamic interaction can influence tumor behavior and patient","cbCaicXRfyESbIYn","https://ap.wps.com/l/cbCaicXRfyESbIYn","pdf",408442,"English","# Introduction\n## Tumor microenvironment and immune surveillance\n## Mechanisms of lymphocyte infiltration\n## Clinical prognostic value of TILs\n## Therapeutic implications","[{\"question\":\"What makes tumor-infiltrating lymphocytes (TILs) important in breast cancer prognosis?\",\"answer\":\"Higher levels of TILs are associated with improved overall survival and disease-free survival, indicating stronger prognostic value across breast cancer contexts.\"},{\"question\":\"Which biological mechanisms support lymphocyte infiltration into tumors?\",\"answer\":\"Lymphocyte recruitment and activity are facilitated by chemokine signaling, antigen presentation, and immune checkpoint interactions, such as the PD-1/PD-L1 axis.\"},{\"question\":\"Do TILs provide different prognostic value across breast cancer subtypes?\",\"answer\":\"Yes. The review highlights the most significant prognostic value in triple-negative and HER2-positive breast cancers, where TIL density correlates with improved outcomes.\"}]","Lymphocyte infiltration in breast cancer - A promising prognostic indicator | PDF",1790024083,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6ef10ff6d51fec762a8e9aa57efee8b8.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7bd1e9258579aafc3ba4b44c12ce59e1.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d63d3cae71c5402e684d192494a23771.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4f4008956069e346e363fb7a32f41838.webp",980,1306]